Related references
Note: Only part of the references are listed.Role of functional pharmacological therapy in post-stroke depression: a narrative review
Francesco Corallo et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Application of Citicoline in Neurological Disorders: A Systematic Review
Patryk Jasielski et al.
NUTRIENTS (2020)
Efficacy, acceptability, and tolerability of antidepressant treatments for patients with post-stroke depression: a network meta-analysis
B. Qin et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2018)
The association of different types of cerebral infarction with post-stroke depression and cognitive impairment
Jun Tu et al.
MEDICINE (2018)
Self-Efficacy, Poststroke Depression, and Rehabilitation Outcomes: Is There a Correlation?
Michele Torrisi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Advances in antidepressants for treating post-stroke depression
Stefano Paolucci
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Good Outcome Isn't Good Enough Cognitive Impairment, Depressive Symptoms, and Social Restrictions in Physically Recovered Stroke Patients
Arunima Kapoor et al.
STROKE (2017)
Interventions for management of post-stroke depression: A Bayesian network meta-analysis of 23 randomized controlled trials
Linghui Deng et al.
SCIENTIFIC REPORTS (2017)
Citicoline Combination Therapy for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Mahtab Roohi-Azizi et al.
CLINICAL NEUROPHARMACOLOGY (2017)
Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression
Xiao-min Xu et al.
MEDICINE (2016)
Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients
Janne Kaergaard Mortensen et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Depression after minor stroke: Prevalence and predictors
Yuzhi Shi et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2015)
Post-stroke depression: an update
G. Esparrago Llorca et al.
NEUROLOGIA (2015)
The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives
Pietro Gareri et al.
CLINICAL INTERVENTIONS IN AGING (2015)
Neural Function, Injury, and Stroke Subtype Predict Treatment Gains after Stroke
Erin Burke Quinlan et al.
ANNALS OF NEUROLOGY (2015)
Normative data for the Montreal Cognitive Assessment in an Italian population sample
Gabriella Santangelo et al.
NEUROLOGICAL SCIENCES (2015)
Screening, Diagnosis, and Treatment of Post-Stroke Depression
Kimberly Dwyer Hollender
JOURNAL OF NEUROSCIENCE NURSING (2014)
Frequency of anxiety after stroke: a systematic review and meta-analysis of observational studies
C. Alexia Campbell Burton et al.
INTERNATIONAL JOURNAL OF STROKE (2013)
Citicoline in Vascular Cognitive Impairment and Vascular Dementia After Stroke
Jose Alvarez-Sabin et al.
STROKE (2011)
A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke
O. Hurtado et al.
NEUROBIOLOGY OF DISEASE (2007)
Citicoline (Cognizin) in the treatment of cognitive impairment
Mario Fioravanti et al.
CLINICAL INTERVENTIONS IN AGING (2006)
Post-stroke and vascular depression: a critical review
L Provinciali et al.
NEUROLOGICAL SCIENCES (2002)
Share Paper
